Publications by authors named "Pehr Lind"

Claim this Profile
P
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
Daniel H Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Pehr Lind

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
Irene A Caspers, Astrid E Slagter, Pehr Lind, Karolina Sikorska, Katja Wiklund

J Surg Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer.
Anders Lideståhl, Emil Fredén, Albert Siegbahn, Gracinda Johansson, Pehr A Lind

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer.
Astrid E Slagter, Irene A Caspers, Nicole C T van Grieken, Iris Walraven, Pehr Lind

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives.
Cecilia Merk, Anna Martling, Johan Lindberg, Léonor Benhaim, Julien Taieb, Pehr Lind

Acta Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial.
Astrid E Slagter, Marieke A Vollebergh, Irene A Caspers, Johanna W van Sandick, Karolina Sikorska, Pehr Lind

Gastric Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams.
Anders Lideståhl, Gracinda Johansson, Albert Siegbahn, Pehr A Lind

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial.
Irene A Caspers, Karolina Sikorska, Astrid E Slagter, Romy M van Amelsfoort, Elma Meershoek-Klein Kranenbarg, Pehr Lind

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial.
Astrid E Slagter, Karolina Sikorska, Cecile Grootscholten, Hanneke W M van Laarhoven, Pehr Lind

Cancer Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial.
Astrid E Slagter, Benjamin Tudela, Romy M van Amelsfoort, Karolina Sikorska, Johanna W van Sandick, Pehr Lind

Eur J Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
Robert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, Paula Ghaneh, Christopher M Halloran, Pehr Lind

JAMA Surg· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours.
Anders Lideståhl, Gracinda Mondlane, Michael Gubanski, Pehr A Lind, Albert Siegbahn

Phys Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Annemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, Karolina Sikorska, Pehr Lind

Lancet Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams.
Gracinda Mondlane, Ana Ureba, Michael Gubanski, Pehr A Lind, Albert Siegbahn

Anticancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases.
Gracinda Mondlane, Michael Gubanski, Pehr A Lind, Ana Ureba, Albert Siegbahn

Phys Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy.
Gracinda Mondlane, Michael Gubanski, Pehr A Lind, Ana Ureba, Albert Siegbahn

Acta Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer.
Gabriella Alexandersson von Döbeln, Magnus Nilsson, Gunnar Adell, Gjermund Johnsen, Ingunn Hatlevoll, Pehr Lind

Pract Radiat Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
John P Neoptolemos, Daniel H Palmer, Paula Ghaneh, Eftychia E Psarelli, Juan W Valle, Pehr Lind

Lancet· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases.
Gracinda Mondlane, Michael Gubanski, Pehr A Lind, Thomas Henry, Ana Ureba

Int J Part Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis.
Andreas Nearchou, Antonis Valachis, Pehr Lind, Olof Akre, Per Sandström

Clin Genitourin Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer.
Ulla Blom Goldman, Gunilla Svane, Martin Anderson, Berit Wennberg, Pehr Lind

Acta Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Antonis Valachis, Andreas D Nearchou, Pehr Lind

Breast Cancer Res Treat· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
Juan W Valle, Daniel Palmer, Richard Jackson, Trevor Cox, John P Neoptolemos, Pehr A Lind

J Clin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.
Antonis Valachis, Nikolaos P Polyzos, Robert E Coleman, Michael Gnant, Holger Eidtmann, Pehr Lind

Oncologist· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac toxicity in breast cancer patients treated with dual HER2 blockade.
Antonis Valachis, Andreas Nearchou, Nikolaos P Polyzos, Pehr Lind

Int J Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis